National Authority for Remote Sensing and Space Sciences

Biophytis provides an update on its early access programs for Sarconeos (BIO101) in the treatment of severe forms of COVID-19

Retrieved on: 
Monday, September 25, 2023
Euronext Growth, CET, Therapy, COVID-19, Pathology, Ageing, National Authority for Remote Sensing and Space Sciences, Element, Abivax, Jiří Sequens, HAS, Patient, Notifiable disease, Respiratory failure, Pharmaceutical industry

After examining the Early Access Authorization request file submitted at the end of May 2023, HAS considered that the Company had not provided sufficient data allowing it to evaluate precisely the benefit vs. risk ratio and to authorize the treatment of patients with severe forms of COVID-19, despite the statistically significant results of the phase 2-3 COVA study.

Key Points: 
  • After examining the Early Access Authorization request file submitted at the end of May 2023, HAS considered that the Company had not provided sufficient data allowing it to evaluate precisely the benefit vs. risk ratio and to authorize the treatment of patients with severe forms of COVID-19, despite the statistically significant results of the phase 2-3 COVA study.
  • At the same time, Biophytis is taking steps in Brazil to confirm the early access authorization obtained in early 2022 that was interrupted pending publication of the full results of the COVA study.
  • This new authorization is expected by the end of the year.
  • Finally, the Company is exploring the possibilities of launching early access programs in other key countries in Europe, in order to best respond to the medical need in a pathology that has become endemic.

CAREMILE launches Its Graphene Wig at the US Wig Exhibition

Retrieved on: 
Monday, April 3, 2023
Ultimate tensile strength, Semiconductor, Hair, Health, Marketing, Steel, Patent, UV, Research institute, National Authority for Remote Sensing and Space Sciences, Carbon fibers

In this context, CAREMILE Co, Ltd. has gained significant attention in the domestic wig industry with the development of the world's first graphene fiber and wigs using graphene fiber.

Key Points: 
  • In this context, CAREMILE Co, Ltd. has gained significant attention in the domestic wig industry with the development of the world's first graphene fiber and wigs using graphene fiber.
  • CAREMILE has registered trademarks for wigs made of graphene fiber, "Graphera" and "BlingBling", as it accelerates marketing activities in order to penetrate foreign markets.
  • In August 2022, CAREMILE filed numerous patent applications related to its graphene wigs constructed from graphene-containing fiber and intended to continue.
  • "Our company promotes the development of various graphene-based healthcare and beauty products with Graphera, a graphene wig fiber, and BlingBling, a graphene wig brand manufactured with Graphera," said Alex Cheon, President of CAREMILE.

Ansys Joins PowerizeD Research Initiative to Enable Sustainable and Resilient Energy Applications

Retrieved on: 
Tuesday, April 11, 2023
National Authority for Remote Sensing and Space Sciences, Partnership, KDT, Workflow, Electronics, Infineon Technologies, ANSYS, Electricity, Intelligence, Research, Key, Digitalization, Organization, Nuclear power debate, Transport, Renewable energy, Cryptocurrency, Mobile phone, Ansys, Horizon Europe, European

PITTSBURGH, April 11, 2023 /PRNewswire/ -- Ansys (NASDAQ: ANSS) joined European research initiative PowerizeD, which focuses on boosting the intelligence of power electronics to make them more efficient. As part of the initiative, Ansys will demonstrate the power of digital twins through new workflows that can increase efficiency, reduce development costs, and contribute to decarbonization efforts.

Key Points: 
  • As part of the initiative, Ansys will demonstrate the power of digital twins through new workflows that can increase efficiency, reduce development costs, and contribute to decarbonization efforts.
  • These workflows are based on Ansys® Twin Builder™ and Ansys® optiSLang™, relying on metamodels built with Ansys® Fluent®, Ansys® Mechanical™, Ansys® Sherlock™, and Ansys® Electronics Desktop™.
  • Digitalization can help here as a highly decisive lever for more energy efficiency," said Constanze Hufenbecher, chief digital transformation officer at Infineon.
  • "We are pleased to combine our strengths with the strengths of so many excellent partners from research and business to jointly make the ambitious European research initiative PowerizeD a success."

Results from the first clinical pilot study using maternal spindle transfer indicate that the technique may have value as a treatment for challenging types of infertility and reveal potential limitations when the method is used for avoidance of mitochondr

Retrieved on: 
Friday, March 17, 2023
DNA, American Society for Reproductive Medicine, Human, Pregnancy, MRTS, University, Life, Reproductive technology, Mitochondrion, Embryo, Infertility, National Authority for Remote Sensing and Space Sciences, Cell, RNA, Cytoplasm, Fertilisation, Female, IVF, Fertility, A-DNA, Patient, Risk, Child, Oregon Health and Science University Center for Women's Health, Oregon Health & Science University, MST, Organelle, Mitochondrial disease, Health, Safety, Egg, Vaccine, Birth control

The exploratory study provides the first insights into safety and efficacy of maternal spindle transfer in humans, when applied in a context of infertility treatment.

Key Points: 
  • The exploratory study provides the first insights into safety and efficacy of maternal spindle transfer in humans, when applied in a context of infertility treatment.
  • Maternal spindle transfer is an advanced laboratory technique that belongs to the family of methods known collectively as mitochondrial replacement therapies (MRTs).
  • The research team aimed to explore, for the first time, the clinical feasibility of the maternal spindle transfer technique in a context of infertility treatment.
  • A definitive assessment of the clinical value of the technique must await future larger, controlled and randomized trials.

Results from the first clinical pilot study using maternal spindle transfer indicate that the technique may have value as a treatment for challenging types of infertility and reveal potential limitations when the method is used for avoidance of mitochondr

Retrieved on: 
Friday, March 17, 2023
DNA, American Society for Reproductive Medicine, Human, Pregnancy, MRTS, University, Life, Reproductive technology, Mitochondrion, Embryo, Infertility, National Authority for Remote Sensing and Space Sciences, Cell, RNA, Cytoplasm, Fertilisation, Female, IVF, Fertility, A-DNA, Patient, Risk, Child, Oregon Health and Science University Center for Women's Health, Oregon Health & Science University, MST, Organelle, Mitochondrial disease, Health, Safety, Egg, Vaccine, Birth control

The exploratory study provides the first insights into safety and efficacy of maternal spindle transfer in humans, when applied in a context of infertility treatment.

Key Points: 
  • The exploratory study provides the first insights into safety and efficacy of maternal spindle transfer in humans, when applied in a context of infertility treatment.
  • Maternal spindle transfer is an advanced laboratory technique that belongs to the family of methods known collectively as mitochondrial replacement therapies (MRTs).
  • The research team aimed to explore, for the first time, the clinical feasibility of the maternal spindle transfer technique in a context of infertility treatment.
  • A definitive assessment of the clinical value of the technique must await future larger, controlled and randomized trials.

Egypt Construction Market Report 2022: Industry to Grow by 10.4% this Year, Supported by Increased Investments in Infrastructure and Energy Projects - ResearchAndMarkets.com

Retrieved on: 
Monday, August 8, 2022
Construction & Property, Other Construction & Property, Central Bank of Egypt, Asian Infrastructure Investment Bank, National Authority for Remote Sensing and Space Sciences, Construction, OPEC Fund for International Development, Industry, Growth, Investment, World Bank, New Administrative Capital, Relaxation, Government, Sector, World, Yoy, National bank, International development, Water, NAC, Electricity, National Bank of Egypt, Commercial, AIIB, CBE, Housing, NBE, Central bank, Renewable energy

The "Egypt Construction Market Size, Trends and Forecast by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and Residential Construction, 2022-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Egypt Construction Market Size, Trends and Forecast by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and Residential Construction, 2022-2026" report has been added to ResearchAndMarkets.com's offering.
  • The Egyptian construction industry grew by an estimated 8% in real terms in 2021, compared to growth of 3% in 2020.
  • The publisher expects the industry to grow by 10.4% this year, supported by increased investments in infrastructure and energy projects.
  • These projects will support investments in the infrastructure and petrochemical sectors, and are expected to drive growth across the construction value chain.

Intelligent Transportation Systems Market size worth $ 96.68 Billion, Globally, by 2030 at 6.7% CAGR: Verified Market Research®

Retrieved on: 
Tuesday, May 17, 2022
Garmin, DMS, CCTV, Research, Thales Group, Intelligent transportation system, DFI, Denso, Government, The Department, NAT, Transport, USD, Efficiency, Department of Infrastructure and Transport, Industry, HAR, Time, Accident, Information, Global, Commercial vehicle operation, Program, National Authority for Remote Sensing and Space Sciences, Safety, Siemens Mobility, CCAM, ITS, Geography, Maintenance, CAGR, Market research, FLIR Systems, Collection, Growth, Cubic Corporation, Civil engineering, Rail transport, Application

JERSEY CITY, N.J., May 17, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Intelligent Transportation Systems Market" By System (Commercial Vehicle Operation, Advanced Traffic Management System), By Application (Automotive Telematics, Collision Avoidance), and By Geography. According to Verified Market Research, the Global Intelligent Transportation Systems Market size was valued at USD 52.59 Billion in 2021 and is projected to reach USD 96.68 Billion by 2030, growing at a CAGR of 6.7% from 2022 to 2030.

Key Points: 
  • According to Verified Market Research, the Global Intelligent Transportation Systems Market size was valued at USD 52.59 Billion in 2021 and is projected to reach USD 96.68 Billion by 2030, growing at a CAGR of 6.7% from 2022 to 2030.
  • Deployment of Intelligent Transport Systems helps in providing real-time traffic statistics which help in resolving increased traffic congestion.
  • Thus growing congestion of traffic is boosting the demand for Intelligent Transportation Systems and thereby increases the growth of the overall market.
  • Verified Market Research has segmented the Global Intelligent Transportation Systems Market On the basis of System, Application, and Geography.

Intelligent Transportation Systems Market size worth $ 96.68 Billion, Globally, by 2030 at 6.7% CAGR: Verified Market Research®

Retrieved on: 
Tuesday, May 17, 2022
Garmin, DMS, CCTV, Research, Thales Group, Intelligent transportation system, DFI, Denso, Government, The Department, NAT, Transport, USD, Efficiency, Department of Infrastructure and Transport, Industry, HAR, Time, Accident, Information, Global, Commercial vehicle operation, Program, National Authority for Remote Sensing and Space Sciences, Safety, Siemens Mobility, CCAM, ITS, Geography, Maintenance, CAGR, Market research, FLIR Systems, Collection, Growth, Cubic Corporation, Civil engineering, Rail transport, Application

JERSEY CITY, N.J., May 17, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Intelligent Transportation Systems Market" By System (Commercial Vehicle Operation, Advanced Traffic Management System), By Application (Automotive Telematics, Collision Avoidance), and By Geography. According to Verified Market Research, the Global Intelligent Transportation Systems Market size was valued at USD 52.59 Billion in 2021 and is projected to reach USD 96.68 Billion by 2030, growing at a CAGR of 6.7% from 2022 to 2030.

Key Points: 
  • According to Verified Market Research, the Global Intelligent Transportation Systems Market size was valued at USD 52.59 Billion in 2021 and is projected to reach USD 96.68 Billion by 2030, growing at a CAGR of 6.7% from 2022 to 2030.
  • Deployment of Intelligent Transport Systems helps in providing real-time traffic statistics which help in resolving increased traffic congestion.
  • Thus growing congestion of traffic is boosting the demand for Intelligent Transportation Systems and thereby increases the growth of the overall market.
  • Verified Market Research has segmented the Global Intelligent Transportation Systems Market On the basis of System, Application, and Geography.

Evasc Neurovascular Announces Enrollment of First Patient in the French eCLIPs™ Safety, Feasibility and Efficacy Study (EESIS-FR)

Retrieved on: 
Thursday, January 13, 2022
Biotechnology, Health, Clinical Trials, Medical Devices, Patient, Technology, NASA eClips, Stroke, Aneurysm, National Authority for Remote Sensing and Space Sciences, Safety, Death, Interventional Neuroradiology, Department, Program, Neurovascular bundle, Neck, Multimedia, HAS, Trial of the century, Pharmaceutical industry, the eCLIPs Aneurysm Treatment System, Evasc, THE ECLIPS ANEURYSM TREATMENT SYSTEM, EVASC

Evasc Neurovascular, a pioneer in the development of disruptive endovascular treatments for cerebral aneurysms, announced today the enrollment of the first patient in its French eCLIPs Safety, Feasibility and Efficacy Study (EESIS-FR).

Key Points: 
  • Evasc Neurovascular, a pioneer in the development of disruptive endovascular treatments for cerebral aneurysms, announced today the enrollment of the first patient in its French eCLIPs Safety, Feasibility and Efficacy Study (EESIS-FR).
  • The study will be conducted in France with the objective to evaluate the technical feasibility, safety, and efficacy of the eCLIPs products for the treatment of bifurcation aneurysms.
  • The eCLIPs device has been granted innovative status in the French Forfait Innovation program and the study is partially funded by the French National Authority for Health (HAS) within this program.
  • Evasc Neurovascular is a privately held medical device company focused on the development of disruptive endovascular treatments for cerebral aneurysms.

MC and Kinki Sharyo Sign Contract with Egyptian Government for Rolling Stock Deliveries for Phase 1 of Cairo Metro Line 4

Retrieved on: 
Tuesday, November 9, 2021
Population, Grand Egyptian Museum, Contract, Line 4, ODA, Kinki Sharyo, MC, Giza pyramid complex, STEP, Urbanization, Program, Japan International Cooperation Agency, New, National Authority for Remote Sensing and Space Sciences, NAT, Railway Systems of Zambia, Mitsubishi Corporation, JICA, Rail transport

The total amount under this contract, in which MC shall serve as the prime contractor, is approximately 40 billion yen.

Key Points: 
  • The total amount under this contract, in which MC shall serve as the prime contractor, is approximately 40 billion yen.
  • Under the terms of the contract, MC will oversee the project's schedule and day-to-day operations and Kinki Sharyo will supply the rolling stock.
  • In November 2020, MC signed a roughly 90-billion-yen contract with the Egyptian government to deliver the Railway Systems, Track and Depot Works Package (CP411) for Phase 1(2).
  • Phase 1 of Cairo Metro Line 4 will run from central Cairo to the Giza Pyramid Complex in Southwest Greater Cairo.